GO:0019771 high-affinity IgG receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019771 high-affinity IgG receptor activity describes the molecular function of binding IgG antibodies with high affinity via their Fc region and transmitting a signal across the membrane to change cell activity.
• The prototypical high-affinity IgG receptor is FcγRI (CD64), which binds monomeric IgG and plays a central role in IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy.
• FcγRI signaling involves inside-out signaling mechanisms that regulate receptor avidity and effector functions.
• High-affinity IgG receptor activity is exploited in engineered immune cells, such as iPSC-derived NK cells expressing CD64/16A fusion receptors for multi-tumor antigen targeting.
• Therapeutic antibodies can engage high-affinity IgG receptors to modulate immune responses, as shown for anti-CTLA-4 and anti-PD-1 antibodies [2,5].
• Dysregulation of high-affinity IgG receptor activity contributes to chronic spontaneous urticaria and other allergic and autoimmune conditions [3,6].
Description
High-affinity IgG receptor activity (GO:0019771) is a molecular function defined as the combination with high affinity with an immunoglobulin of an IgG isotype via the Fc region, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. This activity is critical for immune surveillance and effector responses, as it allows cells to detect and respond to IgG antibodies bound to targets or in immune complexes. The best-characterized high-affinity IgG receptor is FcγRI (CD64), which is expressed on monocytes, macrophages, dendritic cells, and activated neutrophils. Unlike low-affinity Fcγ receptors, FcγRI can bind monomeric IgG with high affinity, enabling it to capture IgG even at physiological concentrations. The signaling mechanisms of FcγRI involve inside-out signaling that modulates receptor clustering and affinity, thereby tuning cellular responses. Understanding this activity is essential for researchers studying antibody-based therapies, autoimmune diseases, and engineered immune cells [2,4,5].
high-affinity IgG receptor activity At A Glance
| GO ID | GO:0019771 |
|---|---|
| GO term | high-affinity IgG receptor activity |
| Ontology | molecular_function |
| Synonym | high affinity Fc receptor activity; high affinity IgG receptor activity |
| Major function | High-affinity binding to IgG Fc region and signal transduction across the membrane |
| Prototypical receptor | FcγRI (CD64) |
| Signaling mechanism | Inside-out signaling modulates receptor avidity and effector functions |
| Therapeutic relevance | Target for antibody engineering and immune cell therapies [2,4,5] |
What Is GO:0019771?
In simple terms, high-affinity IgG receptor activity is the ability of a cell surface receptor to grab IgG antibodies tightly and convert that binding into a signal inside the cell. According to the Gene Ontology, this function involves combining with high affinity with an immunoglobulin of an IgG isotype via the Fc region, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. This activity is distinct from low-affinity IgG receptors because it can bind monomeric IgG, not just immune complexes.
Why Is high-affinity IgG receptor activity Important in Cell Biology?
High-affinity IgG receptor activity is a cornerstone of humoral immunity and antibody-mediated effector functions. It enables cells to respond to IgG antibodies with high sensitivity, which is crucial for pathogen clearance, antitumor immunity, and regulation of inflammatory responses. Dysregulation of this activity can lead to autoimmune and allergic diseases, such as chronic spontaneous urticaria. Moreover, therapeutic antibodies often rely on engaging high-affinity IgG receptors to exert their effects, as seen with anti-CTLA-4 and anti-PD-1 antibodies [2,5]. Engineering high-affinity IgG receptors into immune cells, such as NK cells, has emerged as a promising strategy for cancer immunotherapy.
• Mediates IgG-mediated inflammation and anaphylaxis through FcγRI (CD64).
• Enhances antitumor immunotherapy by promoting antibody-dependent cellular cytotoxicity.
• Contributes to the efficacy of immune checkpoint inhibitors like anti-CTLA-4 and anti-PD-1 antibodies [2,5].
• Involved in the pathogenesis of chronic spontaneous urticaria with or without angioedema.
• Allergen-specific IgG responses can engage high-affinity receptors to modulate allergic inflammation.
• Engineered high-affinity IgG receptor fusion proteins (CD64/16A) enable flexible targeting of multiple tumor antigens in NK cells.
• Inside-out signaling of FcγRI regulates receptor avidity and downstream effector functions.
• Target for therapeutic antibody design to optimize Fc effector functions [1,5].
• Potential biomarker for autoimmune and inflammatory conditions.
• Key component in preclinical models of antibody-mediated diseases.
Molecular Mechanism of high-affinity IgG receptor activity
IgG Binding and Receptor Activation
In simple terms: The receptor grabs IgG antibodies tightly and gets activated.
High-affinity IgG receptors, such as FcγRI (CD64), bind the Fc region of IgG with high affinity, allowing them to capture monomeric IgG even at physiological concentrations. This binding induces receptor clustering and phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs) in associated signaling subunits, initiating downstream signaling cascades.
Inside-Out Signaling and Avidity Regulation
In simple terms: The cell can change how tightly the receptor binds IgG from the inside.
Inside-out signaling modulates the affinity and avidity of FcγRI for IgG. This process involves intracellular signaling pathways that alter the receptor's conformation or clustering, thereby enhancing its ability to bind IgG and trigger effector functions.
Signal Transduction and Cellular Responses
In simple terms: The signal travels into the cell and triggers actions like inflammation or killing.
Upon IgG binding, high-affinity IgG receptors transmit signals across the membrane, leading to activation of Syk kinase, calcium mobilization, and activation of transcription factors such as NF-κB and NFAT. These signals drive cellular responses including phagocytosis, cytokine release, and antibody-dependent cellular cytotoxicity.
Modulation by Therapeutic Antibodies
In simple terms: Drugs that are antibodies can also bind these receptors and change immune responses.
Therapeutic antibodies can engage high-affinity IgG receptors to modulate immune responses. For example, anti-PD-1 antibodies can bind FcγRI, impacting their biological functions. Similarly, anti-CTLA-4 antibodies require Fc effector function for optimal activity, which involves high-affinity IgG receptor engagement.
Engineering High-Affinity Receptors for Therapy
In simple terms: Scientists can design receptors to make immune cells better at attacking tumors.
High-affinity IgG receptor fusion proteins, such as CD64/16A, have been engineered into iPSC-derived NK cells to mediate flexible, multi-tumor antigen targeting for lymphoma. This approach leverages the high-affinity binding of CD64 to IgG antibodies, allowing NK cells to recognize a broad range of tumor antigens through therapeutic antibodies.
Key Genes Involved in GO:0019771 high-affinity IgG receptor activity
The following genes and proteins are central to high-affinity IgG receptor activity and its downstream signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FCGR1A | Encodes FcγRI (CD64), the high-affinity IgG receptor | Prototypical receptor for studying high-affinity IgG binding and signaling |
| FCGR1B | Encodes a FcγRI-related protein | May contribute to high-affinity IgG receptor activity in specific cell types |
| FCGR1C | Encodes a FcγRI-related protein | Potential pseudogene or variant with unclear function |
| FCER1G | Encodes the Fc receptor gamma chain, a signaling subunit | Essential for ITAM-mediated signaling of FcγRI |
| SYK | Spleen tyrosine kinase, key downstream effector | Mediates signaling downstream of high-affinity IgG receptor activation |
| LYN | Src-family kinase that phosphorylates ITAMs | Initiates signaling cascade upon FcγRI engagement |
| PLCG1 | Phospholipase C gamma 1, produces IP3 and DAG | Drives calcium mobilization and PKC activation |
| PIK3CD | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | Contributes to PI3K signaling downstream of FcγRI |
| AKT1 | Serine/threonine kinase, promotes cell survival and proliferation | Downstream of PI3K in FcγRI signaling |
| MAPK1 | Mitogen-activated protein kinase 1 (ERK2) | Transmits signals to nucleus for gene expression |
| NFKB1 | NF-kappa-B transcription factor | Activates inflammatory gene expression upon FcγRI signaling |
| NFATC1 | Nuclear factor of activated T cells, cytoplasmic 1 | Regulates cytokine production and effector functions |
| CBL | E3 ubiquitin ligase, regulates receptor downregulation | Modulates FcγRI stability and signaling duration |
| INPP5D | SHIP1, inositol phosphatase, negative regulator | Limits PI3K signaling downstream of FcγRI |
| PTPN6 | SHP-1, protein tyrosine phosphatase, negative regulator | Attenuates FcγRI signaling |
| CD64 | Alternative name for FcγRI (CD64) | Target for engineered NK cell therapies |
| FCGR2A | Low-affinity IgG receptor, often co-expressed | Modulates overall IgG-mediated responses |
| FCGR3A | Low-affinity IgG receptor, mediates ADCC | Cooperates with high-affinity receptors in effector functions |
How Is high-affinity IgG receptor activity Regulated?
High-affinity IgG receptor activity is regulated at multiple levels. Inside-out signaling modulates receptor avidity and clustering in response to cellular activation. Phosphorylation of ITAMs by Src-family kinases like LYN initiates signaling, while phosphatases such as SHP-1 and SHIP1 provide negative feedback. Receptor expression levels can be altered by cytokines, and therapeutic antibodies can compete for FcγRI binding, thereby modulating activity. Additionally, the Fc region of IgG antibodies can be engineered to enhance or reduce binding to high-affinity receptors, as demonstrated with rozanolixizumab, an anti-FcRn antibody that reduces plasma IgG concentration.
high-affinity IgG receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FCGR1A | Autoimmune inflammation, anaphylaxis | Fcgr1 knockout mouse |
| FCGR1A | Chronic spontaneous urticaria | Human mast cell lines with FCGR1A knockdown |
| FCGR1A | Cancer immunotherapy | iPSC-derived NK cells expressing CD64/16A |
| FCGR1A | Antibody-mediated effector functions | Humanized mouse models |
| FCGR1A | Allergic inflammation | Allergen-challenged mouse models |
Autoimmune and Inflammatory Diseases
High-affinity IgG receptor activity is implicated in autoimmune and inflammatory conditions. In chronic spontaneous urticaria, IgG autoantibodies can engage high-affinity receptors on mast cells and basophils, leading to histamine release and wheal formation. FcγRI (CD64) promotes IgG-mediated inflammation and anaphylaxis in preclinical models. Targeting this activity may offer therapeutic benefits in such diseases.
Cancer Immunotherapy
High-affinity IgG receptor activity enhances antitumor immunity by facilitating antibody-dependent cellular cytotoxicity and phagocytosis. Anti-CTLA-4 antibodies require Fc effector function, including engagement of high-affinity IgG receptors, for optimal antitumor activity. Similarly, anti-PD-1 antibodies can bind FcγRI, which may influence their therapeutic effects. Engineering high-affinity receptors into immune cells, such as CD64/16A in NK cells, represents a promising strategy for cancer immunotherapy.
Allergy
Allergen-specific IgG antibodies can engage high-affinity IgG receptors to modulate allergic responses. The effector function of allergens may involve IgG-mediated activation of FcγRI, contributing to allergic inflammation. Understanding these interactions is important for developing therapies for allergic diseases.
From high-affinity IgG receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does FCGR1A mediate IgG-induced inflammation? | FCGR1A knockout mouse |
| How does inside-out signaling regulate FcγRI avidity? | Point mutations in FCGR1A signaling motifs |
| Can high-affinity IgG receptor enhance NK cell therapy? | Knock-in of CD64/16A into iPSC-derived NK cells |
| What is the role of FcγRI in anti-CTLA-4 therapy? | FCGR1A humanized mouse models |
| How does FcγRI binding affect anti-PD-1 antibody function? | Overexpression of FCGR1A in cell lines |
| Can FCGR1A be targeted to treat urticaria? | Patient-derived mast cells with CRISPR knockout |
How to Study the high-affinity IgG receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Surface plasmon resonance (SPR) | Binding affinity and kinetics of IgG to FcγRI | Antibody engineering and receptor characterization |
| Phosphoproteomics | Phosphorylation of signaling proteins | Mapping FcγRI signaling pathways |
| Calcium flux assay | Intracellular calcium mobilization | Functional readout of receptor activation |
| ADCC assay | Target cell killing by effector cells | Evaluating therapeutic antibody efficacy |
| Phagocytosis assay | Engulfment of IgG-coated targets | Assessing FcγRI-mediated phagocytosis |
| CRISPR knockout screen | Genes required for receptor function | Identifying novel regulators of high-affinity IgG receptor activity |
| Flow cytometry | Cell surface expression of FcγRI | Phenotyping immune cells and engineered lines |
| ELISA | Cytokine release upon receptor activation | Measuring inflammatory responses |
Binding Affinity Measurements
Surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) are used to measure the binding affinity of IgG to high-affinity receptors like FcγRI. These methods provide quantitative data on association and dissociation rates, which are critical for understanding receptor function and engineering therapeutic antibodies.
Signaling Pathway Analysis
Phosphoproteomics and Western blotting can assess phosphorylation events downstream of FcγRI activation, including ITAM phosphorylation and Syk activation. Calcium flux assays using fluorescent dyes measure intracellular calcium mobilization, a key readout of high-affinity IgG receptor signaling.
Functional Assays
Antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis assays are used to evaluate the functional consequences of high-affinity IgG receptor activity. These assays typically use target cells coated with IgG antibodies and effector cells expressing FcγRI, measuring target cell killing or engulfment.
Genetic Engineering and CRISPR Screens
CRISPR-Cas9 knockout screens can identify genes required for high-affinity IgG receptor activity and downstream signaling. Knock-in of reporter genes or tagged receptors allows real-time monitoring of receptor expression and localization. Overexpression of FCGR1A in cell lines can enhance sensitivity to IgG-mediated activation.
How CRISPR Can Be Used to Study GO:0019771 high-affinity IgG receptor activity
Knockout
CRISPR-Cas9 knockout of FCGR1A or its signaling partners (e.g., FCER1G, SYK) can abolish high-affinity IgG receptor activity, providing a clean background to study its specific contributions to cellular responses. Knockout models are essential for validating the role of FcγRI in inflammation and antitumor immunity.
Point Mutation
Introducing point mutations in the ITAM motifs of FCER1G or in the IgG-binding domain of FCGR1A can dissect the molecular requirements for high-affinity IgG receptor signaling. Such mutations help distinguish between binding and signaling functions and reveal inside-out signaling mechanisms.
Knock-in
Knock-in of tagged or fluorescently labeled FCGR1A allows real-time imaging of receptor trafficking and clustering. Knock-in of human FCGR1A into mouse models humanizes the receptor for testing therapeutic antibodies. Additionally, knock-in of CD64/16A fusion into iPSC-derived NK cells enhances their antitumor activity.
Overexpression
Overexpression of FCGR1A in cell lines increases sensitivity to IgG-mediated activation, enabling studies of downstream signaling and effector functions. Overexpression models are useful for screening therapeutic antibodies that engage high-affinity IgG receptors.
How EDITGENE Supports high-affinity IgG receptor activity Research
Researchers studying high-affinity IgG receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor function, signaling, or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for high-affinity IgG receptor activity research.
Frequently Asked Questions About high-affinity IgG receptor activity
What is high-affinity IgG receptor activity?
High-affinity IgG receptor activity (GO:0019771) is a molecular function where a receptor binds IgG antibodies with high affinity via their Fc region and transmits a signal across the membrane to change cell activity.
What genes are involved in high-affinity IgG receptor activity?
Key genes include FCGR1A (encoding FcγRI/CD64), FCER1G (signaling subunit), SYK, LYN, and other downstream signaling molecules.
What is the role of FcγRI (CD64) in immunity?
FcγRI (CD64) is the prototypical high-affinity IgG receptor that promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy.
How does inside-out signaling regulate high-affinity IgG receptors?
Inside-out signaling modulates the avidity and clustering of FcγRI in response to cellular activation, thereby tuning effector functions.
Which diseases are associated with high-affinity IgG receptor activity?
It is implicated in autoimmune diseases like chronic spontaneous urticaria, allergic inflammation, and cancer immunotherapy responses [2,3,6].
How can CRISPR be used to study high-affinity IgG receptor activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of receptor function and signaling in immune cells [4,7,8].
What are the therapeutic implications of targeting high-affinity IgG receptors?
Therapeutic antibodies can be engineered to engage or block high-affinity IgG receptors to modulate immune responses in cancer and autoimmune diseases [1,2,5].
What methods are used to measure high-affinity IgG receptor activity?
Surface plasmon resonance, phosphoproteomics, calcium flux assays, ADCC assays, and phagocytosis assays are commonly used [1,7,8].
Can high-affinity IgG receptors be engineered into immune cells for therapy?
Yes, iPSC-derived NK cells expressing CD64/16A fusion receptors have been developed for multi-tumor antigen targeting in lymphoma.
What is the difference between high-affinity and low-affinity IgG receptors?
High-affinity receptors like FcγRI bind monomeric IgG, while low-affinity receptors primarily bind IgG in immune complexes.
Conclusion
High-affinity IgG receptor activity (GO:0019771) is a critical molecular function that bridges humoral immunity and cellular effector responses. Its prototypical mediator, FcγRI (CD64), is central to IgG-mediated inflammation, anaphylaxis, and antitumor immunity. Dysregulation of this activity contributes to autoimmune and allergic diseases, while its engagement is exploited by therapeutic antibodies and engineered immune cells [2,3,4,5]. Understanding the mechanisms of high-affinity IgG receptor signaling, including inside-out regulation, offers opportunities for therapeutic intervention. EDITGENE provides comprehensive CRISPR services to model and study this activity, empowering researchers to advance the field.
References
- 1. Smith B et al.. 2018. Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration.. MAbs 10(7):1111-1130 PMID: 30130439
- 2. Arce Vargas F et al.. 2018. Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.. Cancer Cell 33(4):649-663.e4 PMID: 29576375
- 3. Saini SS et al.. 2025. Pathogenesis of Chronic Spontaneous Urticaria With or Without Angioedema.. J Allergy Clin Immunol Pract 13(9):2221-2228 PMID: 40721160
- 4. Dixon KJ et al.. 2024. iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphoma.. Front Immunol 15:1407567 PMID: 39100677
- 5. Zhang T et al.. 2018. The binding of an anti-PD-1 antibody to FcγRΙ has a profound impact on its biological functions.. Cancer Immunol Immunother 67(7):1079-1090 PMID: 29687231
- 6. Hazebrouck S et al.. 2022. The Effector Function of Allergens.. Front Allergy 3:818732 PMID: 35386644
- 7. Mancardi DA et al.. 2013. The high-affinity human IgG receptor FcγRI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy.. Blood 121(9):1563-73 PMID: 23293080
- 8. Brandsma AM et al.. 2018. Mechanisms of inside-out signaling of the high-affinity IgG receptor FcγRI.. Sci Signal 11(540) PMID: 30042128
